Evidence map›Paper›PMID 26286990›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Cyclin-dependent kinase 5 activates guanine nucleotide exchange factor GIV/Girdin to orchestrate migration-proliferation dichotomy.

Deepali Bhandari, Inmaculada Lopez-Sanchez, Andrew To, I-Chung Lo, Nicolas Aznar, Anthony Leyme, Vijay Gupta, Ingrid Niesman, Adam L Maddox, Mikel Garcia-Marcos and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 65 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. CDK5: Insights into its roles in diseases.Molecular biology reports · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Receptor tyrosine kinases activate heterotrimeric G proteins via phosphorylation within the interdomain cleft of Gαi.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  14. Article
  15. CDK5 Inhibition Abrogates TNBC Stem-Cell Property and Enhances Anti-PD-1 Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2020
    Article
  16. Article
  17. Ric-8A, a GEF, and a Chaperone for G Protein α-Subunits: Evidence for the Two-Faced Interface.BioEssays : news and reviews in molecular, cellular and developmental biology · 2020
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Deepali BhandariDepartment of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093-0651; Department of Chemistry and Biochemistry, California State University Long Beach, Long Beach, CA 90840-9507; prghosh@ucsd.edu deepali.bhandari@csulb.edu mfarquhar@ucsd.edu.
Inmaculada Lopez-SanchezDepartment of Medicine, University of California at San Diego, La Jolla, CA 92093-0651;
Andrew ToDepartment of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093-0651;
I-Chung LoDepartment of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093-0651;
Nicolas AznarDepartment of Medicine, University of California at San Diego, La Jolla, CA 92093-0651;
Anthony LeymeDepartment of Biochemistry, Boston University School of Medicine, Boston, MA 02118.
Vijay GuptaDepartment of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093-0651;
Ingrid NiesmanDepartment of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093-0651;
Adam L MaddoxDepartment of Chemistry and Biochemistry, California State University Long Beach, Long Beach, CA 90840-9507;
Mikel Garcia-MarcosDepartment of Biochemistry, Boston University School of Medicine, Boston, MA 02118.
Marilyn G FarquharDepartment of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093-0651; prghosh@ucsd.edu deepali.bhandari@csulb.edu mfarquhar@ucsd.edu.
Pradipta GhoshDepartment of Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA 92093-0651; Department of Medicine, University of California at San Diego, La Jolla, CA 92093-0651; prghosh@ucsd.edu deepali.bhandari@csulb.edu mfarquhar@ucsd.edu.
University of California, San Diego · USBoston University · USCalifornia State University, Long Beach · US

Funding

Training Grant in GastroenterologyT32DK007202 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 1985 to 2022
$7.7M
Spatial Regulation of RGS and G Protein SignalingR01CA100768 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 2003 to 2019
$7.4M
Modulation of G proteins by Growth FactorsR01CA160911 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 2013 to 2017
$1.8M
Alternative mechanisms of signaling via trimeric G proteinsR01GM108733 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI GARCIA-MARCOS, MIKEL · 2014 to 2018
$1.6M
G Protein pathways as Novel Therapeutic and Diagnostic Targets in Liver FibrosisR01DK099226 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GHOSH, PRADIPTA · 2014 to 2016
$698k
NCI NIH HHS CA100768NCI NIH HHS CA160911NCI NIH HHS R01 CA100768NCI NIH HHS R01 CA160911NIDDK NIH HHS DK099226NIDDK NIH HHS R01 DK099226NIDDK NIH HHS T32 DK007202NIGMS NIH HHS R01 GM108733NIGMS NIH HHS R01GM108733
6 · The paper itself

Abstract

Signals propagated by receptor tyrosine kinases (RTKs) can drive cell migration and proliferation, two cellular processes that do not occur simultaneously--a phenomenon called "migration-proliferation dichotomy." We previously showed that epidermal growth factor (EGF) signaling is skewed to favor migration over proliferation via noncanonical transactivation of Gαi proteins by the guanine exchange factor (GEF) GIV. However, what turns on GIV-GEF downstream of growth factor RTKs remained unknown. Here we reveal the molecular mechanism by which phosphorylation of GIV by cyclin-dependent kinase 5 (CDK5) triggers GIV's ability to bind and activate Gαi in response to growth factors and modulate downstream signals to establish a dichotomy between migration and proliferation. We show that CDK5 binds and phosphorylates GIV at Ser1674 near its GEF motif. When Ser1674 is phosphorylated, GIV activates Gαi and enhances promigratory Akt signals. Phosphorylated GIV also binds Gαs and enhances endosomal maturation, which shortens the transit time of EGFR through early endosomes, thereby limiting mitogenic MAPK signals. Consequently, this phosphoevent triggers cells to preferentially migrate during wound healing and transmigration of cancer cells. When Ser1674 cannot be phosphorylated, GIV cannot bind either Gαi or Gαs, Akt signaling is suppressed, mitogenic signals are enhanced due to delayed transit time of EGFR through early endosomes, and cells preferentially proliferate. These results illuminate how GIV-GEF is turned on upon receptor activation, adds GIV to the repertoire of CDK5 substrates, and defines a mechanism by which this unusual CDK orchestrates migration-proliferation dichotomy during cancer invasion, wound healing, and development.

Indexed as

Cell MovementCell ProliferationAmino Acid SequenceAnimalsCyclin-Dependent Kinase 5ErbB ReceptorsHumansMicrofilament ProteinsMolecular Sequence DataMorphogenesisPhosphorylationProtein TransportSequence Homology, Amino AcidSignal TransductionVesicular Transport ProteinsWound HealingCCDC88A protein, humanCDK5 protein, humanCyclin-Dependent Kinase 5ErbB ReceptorsMicrofilament ProteinsVesicular Transport ProteinsGIV/Girdingrowth factor receptor tyrosine kinaseguanine nucleotide exchange factorheterotrimeric G proteinmigration–proliferation dichotomy

Identifiers

PMID26286990
PMCPMC4568279
OpenAlexW1955181723

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.